Centene’s stock pulled a sharp U-turn into the green, after the health insurer helped assuage investor worries by providing details on its full-year outlook, and by suggesting the worst will pass soon.

Health coverage company Centene (NYSE:CNC) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 22.4% year on year to $48.74 billion. Its non-GAAP loss of $0.16 per share was significantly below analysts’ consensus estimates.

Centene is responding by repricing plans for 2026 and focusing on cost controls while Medicare Advantage and Prescription Drug segments outperform expectations. Learn more on CNC stock here.

Shares of Centene are trading lower on Thursday, hitting a new 52-week low. A rival's profit warning fueled investor anxiety over government-sponsored healthcare.

In its second quarter, the Clayton-based company lost $253 million dollars, 51 cents a share. In the same period last year, Centene saw earnings of $2.26 a share.

Centene is trading at half of book value and under 9x earnings, an extreme undervaluation for a cash-generating insurer. See why I rate CNC stock a Buy.

Intel (NASDAQ: INTC) stock slumped 8% after the chipmaker forecast steeper losses than expected in the third quarter and announced plans to slash jobs, reducing headcount to 75,000 by the end of year, down 22% from the end of 2024, which will be through attrition and "other means".

Shares of Centene are experiencing a historic collapse this week. Wednesday marked the worst single-day performance in the company's history. Tim Melvin’s system has spotted 10X winners like ...

Shares of Centene ( NYSE: CNC) lost ~10% in the premarket on Friday after the Medicaid-driven managed care firm fell short of earnings expectations with its Q2 2025 results, recording its first quarterly earnings miss in four years.